Arthritis in the intensive care unit

Critical Care Clinics

Volumn 18, Issue 4, 2002, Pages 767-780

  Raj, Jaya M ^a,b,c   Sudhakar, Sheila ^c   Sems, Kelly ^c   Carlson, Richard W ^a,b,c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c MARICOPA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANALGESIC AGENT; AZITHROMYCIN; CALCIUM PYROPHOSPHATE; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; COLCHICINE; CORTICOSTEROID; CORTICOTROPIN; DOXYCYCLINE; DYSPROSIUM; DYSPROSIUM 165; FRESH FROZEN PLASMA; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; RADIOISOTOPE; STEROID; UNCLASSIFIED DRUG; VITAMIN K GROUP; YTTRIUM 90;

ANTIBIOTIC THERAPY; ARTHRITIS; BACTERIAL ARTHRITIS; BONE MARROW TOXICITY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL TOXICITY; GOUT; HEMARTHROSIS; HUMAN; INTENSIVE CARE UNIT; JOINT PROSTHESIS; JOINT RADIOGRAPHY; LABORATORY TEST; LIVER TOXICITY; NEPHROTOXICITY; PRIORITY JOURNAL; PROSTHESIS INFECTION; PSEUDOGOUT; REVIEW; RISK FACTOR; SURGICAL DRAINAGE; SYNOVIAL FLUID;

ARTHRITIS; ARTHRITIS, INFECTIOUS; CHONDROCALCINOSIS; GOUT; HEMARTHROSIS; HUMANS; INTENSIVE CARE; RISK FACTORS;

EID: 0036839167     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(02)00021-0     Document Type: Review

References (65)

1. Kaandorp CJE, van Schaardenburg D, Krijnen P, et al. Risk factors for septic arthritis in patients with joint disease: A prospective study. Arthritis Rheum 1995;38:1819-25.
2. Gupta MN, Sturrock RD, Field M. A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatology 2001;40:24-30.
3. Weston VC, Jones AC, Bradbury N, et al. Clinical features and outcome of septic arthritis in a single UK health district 1982-1991. Ann Rheum Dis 1999;58(4):214-9.
4. Martens PB, Ho G. Septic arthritis in adults: Clinical features, outcome, and intensive care requirements. Journal of Intensive Care Medicine 1995;10(5):246-52.
5. Goldenberg DL. Septic arthritis. Lancet 1998;351:197-202.
6. Lane-Smith R, Schurman DJ. Bacterial arthritis: A Staphylococcal proteoglycan-releasing factor. Arthritis Rheum 1986;29(11):1378-86.
7. Dubost JJ, Fis I, Denis P, et al. Polyarticular septic arthritis. Medicine (Baltimore) 1993;72:296-310.
8. Epstein JH, Zimmermarm B, Ho G. Polyarticular septic arthritis. J Rheumatol 1986;13(6):1105-7.
9. Goldenberg DL. Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum 1989;32:496-50
10. Ostensson A, Geborek P. Septic arthritis as a non-surgical complication in rheumatoid arthritis: Relation to disease severity and therapy. Br J Rheumatol 1991;30:35-8.
11. Ilahi OA, Swama U, Hamill RJ, et al. Concomitant crystal and septic arthritis. Orthopedics 1996;19(7):613-7.
12. Blackburn WD, Dunn TL, Alarcon GS. Infection versus disease activity in rheumatoid arthritis: Eight years' experience. South Med J 1986;79(10):1238-41.
13. Rivera J, Monteagudo I, Lopez-Longo J. Septic arthritis in patients with acquired immunodeficiency syndrome with human immunodeficiency virus infection. J Rheumatol 1992;19(12):1960-2.
14. Goldenberg DL. Septic arthritis and other infections of rheumatologic significance. Rheum Dis Clin North Am 1991;17(1):149-56.
15. Ang-Fonte GZ, Rozboril MB, Thompson GR. Changes in nongonococcal septic arthritis: Drug abuse and methicillin-resistant Staphylococcus aureus. Arthritis Rheum 1985;28:210-3.
16. Munoz-Fernandez S, Macia MA, Pantoja L, et al. Osteoarticular infection in intravenous drug abusers: Influence of HIV infection and differences with non drug abusers. Ann Rheum Dis 1993;52:570-4.
17. Churchill MA, Geraci JE, Hunder GG. Musculoskeletal manifestations of bacterial endocarditis. Ann Intern Med 1977;87:754-9.
18. Sapico FL, Liquete JA, Sarma RJ. Bone and joint infections in patients with infective endocarditis: Review of a 4-year experience. Clin Infect Dis 1996;22:783-7.
19. Gonzalez-Juanatey C, Gonzalez-Gay MA, Llorca J, et al. Rheumatic manifestations of infective endocarditis in non-addicts. Medicine (Baltimore) 2001;80:9-19.
20. Ho G. Bacterial arthritis. Curr Opin Rheumatol 1993;5:449-53.
21. Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med 1985;312:764-71.
22. Forrester DM, Fenske WI. Imaging of infectious arthritis. Semin Roentgenol 1996;31:239-49.
23. Mikhail IS, Alarcon GS. Nongonococcal bacterial arthritis. Rheum Dis Clin North Am 1993;19(2):311-31.
24. Donatto KC. Orthopedic management of septic arthritis. Rheum Dis Clin North Am 1998;24(2):275-86.
25. Goldenberg DL, Brandt KD, Cohen AS, et al. Treatment of septic arthritis: Comparison of needle aspiration and surgery as initial modes of joint drainage. Arthritis Rheum 1975;18:83-90.
26. Maderazo EG, Judson S, Pasternak H. Late infections of total joint prostheses: A review and recommendations for prevention. Clin Orthop 1988;229:131-42.
27. Maguire JH. Advances in the control of perioperative sepsis in total joint replacement. Rheum Dis Clin North Am 1988;14:519-35.
28. Scopelitis E, Martinez-Osuna P. Gonococcal arthritis. Rheum Dis Clin North Am 1993;19(2):363-77.
29. Hook EW, Holmes KK. Gonococcal infections. Ann Intern Med 1985;102:229-43.
30. Keat A. Sexually transmitted arthritis syndromes. Med Clin North Am 1990;74:1617-31.
31. Mahowald ML. Septic arthritis. In: Klippel, JH, Weyand CM, Wortmann RL, editors. Primer on the Rheumatic Diseases. 11th Edition. Atlanta (GA): Arthritis Foundation; 1997. p. 196-200.
32. Naides SJ. Viral arthritis. In: Klippel, JH, Weyand CM, Wortmann RL, editors. Primer on the Rheumatic Diseases. 11th Edition, Atlanta (GA): Arthritis Foundation; 1997. p. 201-4.
33. Abbott RD, Brand FN, Kannel WB, et al. Gout and coronary artery disease. The Framingham study. J Clin Epidemiol 1988;41:237-42.
34. Agudelo CA, Wise CM. Crystal-associated arthritis. Clin Geriatr Med 1998;14(3):495-513.
35. Agudelo CA, Wise CM. Crystal-associated arthritis in the elderly. Rheum Dis Clin North Am 2000;26(3):527-46.
36. Diamond HS. Control of crystal-induced arthropathies. Rheum Dis Clin North Am 1989;15(3):557-67.
37. Becker MA. Clinical aspects of monosodium urate monohydrate crystal deposition disease. Rheum Dis Clin North Am 1988;14(2):377-95.
38. Grahame R, Scott JT. Clinical survey of 354 patients with gout. Ann Rheum Dis 1970;29:461.
39. Michet CJ, Evans JM, Fleming KC. Common rheumatologic diseases in elderly patients. Mayo Clin Proc 1995;70(12):1205-14.
40. Malawista SE, Duff GW, Atkins E, et al. Crystal-induced endogenous pyrogen production: A further look at gouty inflammation. Arthritis Rheum 1985;28(9):1039-46.
41. Terkeltaub RA. Gout and mechanisms of crystal induced inflammation. Curr Opin Rhematol 1993;5:510-6.
42. Kelley WN, Wortman RL. Gout and hyperuricemia. In: Kelley WN, Harris ED, Ruddy S, et al, editors. Textbook of Rheumatology. 5th Edition. Philadelphia (PA): WB Saunders; 1997. p. 1313-51.
43. Simkin PA, Campbell PM, Larson EB. Gout in Heberden's nodes. Arthritis Rheum 1983;26:94-7.
44. Schumacher Jr. HR. Synovial fluid analysis and synovial biopsy. In: Kelley WN, Harris Jr. ED, Ruddy S, et al, editors. Textbook of Rheumatology. 14th Edition. Philadelphia (PA): WB Saunders; 1993. p. 562-78.
45. Emmerson BT. The management of acute gout. N Engl J Med 1996;344:445-51.
46. Putterman C, Ben-Chetrit E, Caraco Y, et al. Colchicine intoxication: Clinical pharmacology, risk factors, features, and management. Semin Arthritis Rheum 1991;21:143-55.
47. Abramson SB. Treatment of gout and crystal arthropathies and uses and mechanisms of action of non-steroidal anti-inflammatory drugs. Curr Opin Rheumatol 1992;4:295-300.
48. Rosenthal AK, Ryan LM. Treatment of refractory crystal-associated arthritis. Rheum Dis Clin North Am 1995;21(1):151-61.
49. Groff GD, Franck WA, Raddatz DA. Systemic steroid therapy for acute gout: A clinical trial and review of the literature. Semin Arthritis Rheum 1990;19:329-36.
50. Alloway JA, Moriarty MJ, Hoogland YT, et al. Comparison of the triamcinalone acetonide with indomethacin in the treatment of acute gouty arthritis. J Rheumatol 1993;F20:111-3.
51. Ritter JM, Kerr LD, Valeriano-Marcet J, et al. The use of parenteral ACTH for acute crystal-induced synovitis in patients with multiple medical problems. Arthritis Rheum 1992;35:S225.
52. Axelrod D, Preston S. Comparison ofparenteral adrenocorticotropic hormone with indomethacin in the treatment of acute gout. Arthritis Rheum 1988;31:803-5.
53. Bjelle A. Familial pyrophosphate arthropathy. Occurrence and crystal identification. Scand J Rheumatol 1981;10(3):209-14.
54. Reginato AJ, Reginato AM, Fernandez-Dapica MP. Familial calcium pyrophosphate crystal deposition disease or calcium pyrophosphate gout. Rev Rhum Engl Ed 1995;62(5):376-91.
55. Doherty M, Dieppe P. Clinical aspects of calcium pyrophosphate dihydrate crystal deposition. Rheum Dis Clin North Am 1988;14(2):395-415.
56. Jones AC, Chuck AJ, Arie EA, et al. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum 1992;22(3):188-202.
57. Halverson PB, McCarty DJ. Clinical aspects of basic calcium phosphate crystal deposition. Rheum Dis Clin North Am 1988;14(2):427-37.
58. Ho G, DeNuccio M. Gout and pseudogout in hospitalized patients. Arch Intern Med 1993;153:2787-90.
59. Tabatabai MR, Cummings NA. Intravenous colchicine in the treatment of acute pseudogout. Arthritis Rheum 1980;23:370.
60. Dieppe P, Campion G, Chir B, et al. Clinical aspects of basic calcium phosphate crystal deposition. Rheum Dis Clin North Am 1988;14(2):427-35.
61. Fam AG. Calcium pyrophosphate crystal deposition disease and other crystal deposition diseases. Curr Opin Rheumatol 1992;4:574-82.
62. Reginato AJ, Ferreiro Seoane JL, Barbazan Alvarez C, et al. Arthropathy and cutaneous calcinosis in hemodialysis oxalosis. Arthritis Rheum 1986;29:1387-96.
63. Upchurch KS, Brettler DB. Hemophilic arthropathy. In: Kelley WN, Harris ED, Ruddy S, et al, editors. Textbook of Rheumatology. 5th Edition, Philadelphia (PA): WB Saunders: 1997. p. 1485-92.
64. Jaffer AM, Schmid FR. Hemarthrosis associated with sodium warfarin. J Rheumatol 1977;4(2):215-7.
65. Wild JH, Zvaifler NJ. Hemarthrosis associated with sodium warfarin therapy. Arthritis Rheum 1976;19(1):98-102.